Robert Bradley

Dr. Bradley is investigating comprehensively the mutations in the SF3B1 protein and their connection with myelodysplastic syndromes (MDS) and leukemias, and exploring this protein as a therapeutic target.

Robert Bradley, Ph.D., is a computational biologist and biophysicist who works at the intersection of several different disciplines, including cancer biology, cancer-immune interactions, and RNA processing. His broad goal is to discover novel molecular mechanisms that govern cancer initiation, progression or response to therapy. He is professor of Public Health Sciences Division and professor of Basic Sciences Division of Fred Hutch.